Halozyme Therapeutics Incorporate.../ US40637H1095 /
| 2024-06-05 10:00:00 PM | Chg. +1.3500 | Volume | Bid11:14:00 PM | Ask11:14:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 45.6500USD | +3.05% | 949,201 Turnover: 30.16 mill. |
45.6600Bid Size: 200 | 46.6900Ask Size: 100 | 45.7800 | 44.3800 |
Business description
-
Management board & Supervisory board
| CEO |
|---|
| Helen Torley |
| Management board |
| Nicole LaBrosse, Mark Snyder, Michael J. LaBarre, Chris Wahl, Cortney Caudill, Tram Bui, Gary Grote, Amy Fox, Steve Knowles, Christopher Bryant, Kristin Schwartzbauer |
| Supervisory board |
| Jeffrey W. Henderson, Jean-Pierre Bizzari, Barbara Duncan, Matthew L. Posard, Connie L. Matsui, Moni Miyashita, Bernadette Connaughton, Helen Torley |
